SCHEMBL23958144

SCHEMBL23958144

Cc1ccccc1-n1c(Nc2cccnc2)nc2c(F)cccc2c1=O

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TP53 P04637 1/20 0.44
PDE7A Q13946 4/20 0.44
ALDH1A1 P00352 2/20 0.41
LMNA P02545 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
PDE4A P27815 1/20 0.41
PDE4B Q07343 1/20 0.41
PDE4C Q08493 1/20 0.41
PDE4D Q08499 1/20 0.41
PDE7B Q9NP56 1/20 0.41
JUN P05412 1/20 0.40
NFKB1 P19838 1/20 0.40
NFKB2 Q00653 1/20 0.40
RELA Q04206 1/20 0.40
GRM4 Q14833 2/20 0.40
KMT2A Q03164 2/20 0.39
JAK1 P23458 1/20 0.39
TYK2 P29597 1/20 0.39
JAK3 P52333 1/20 0.39
MEN1 O00255 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23958201 0.86 ALOX12 (0.43) PDE7ALMNAKMT2AJAK1TYK2
SCHEMBL23958344 0.83 PIK3CD (0.45) TP53PDE7AALDH1A1LMNAL3MBTL1
SCHEMBL23958356 0.82 ALOX12 (0.48) PDE7ALMNAKMT2AMEN1ALOX12
SCHEMBL30103275 0.80 TDO2 (0.48) TP53PDE7AALDH1A1LMNAL3MBTL1
SCHEMBL23958346 0.80 PDE7A (0.46) TP53PDE7AALDH1A1LMNAL3MBTL1
SCHEMBL23958208 0.80 TDO2 (0.48) TP53PDE7AALDH1A1LMNAL3MBTL1
SCHEMBL24111001 0.74 PIK3CD (0.41) PDE7AALDH1A1L3MBTL1KMT2AALOX12
SCHEMBL23958205 0.74 TDO2 (0.48) L3MBTL1KMT2ARAD52
SCHEMBL30103287 0.74 PIK3CD (0.41) PDE7AALDH1A1L3MBTL1KMT2AALOX12
SCHEMBL30103212 0.74 TDO2 (0.48) L3MBTL1KMT2ARAD52

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210387967-A1 2-HETEROARYL AMINOQUINAZOLINONE DERIVATIVE SUMITOMO DAINIPPON PHARMA CO., LTD. (JP) 2021-12-16 US disclosed
WO-2021215537-A1 2-HETEROARYLAMINOQUINAZOLINONE DERIVATIVE 大日本住友製薬株式会社 (JP) 2021-10-28 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210387967-A1 2-HETEROARYL AMINOQUINAZOLINONE DERIVATIVE CRKL, CLIC4, CLIC1 TP53 3842/4885PDE7A 3371/4885ALDH1A1 1803/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.